Eplontersen,Inotersen
Ionis Pharmaceuticals,Akcea Therapeutics,Astrazeneca
['eplontersen', 'astrazeneca']
use of eplontersen led to significant reduction of hereditary transthyretin-mediated amyloid #polyneuropathy progression speed compared to external placebo control #visualabstract #neurology 
Here, is the CLINICAL TRIAL OF THE DAY 
The interesting clinical study with impact on future clinical practice 
// Our editor's opinion only //